Martin Shkreli, a capitalist or criminal?
1. Martin Shkreli, the CEO of Turing Pharmaceuticals, has had an interesting week. The 32-year-old made headlines when he hiked the price of Daraprim, a drug he owns rights to, from $13.50 per pill to $750, despite the pill's $1 manufacturing cost. Shkreli defended his actions, claiming that his company needed to "turn a profit" on the drug.
2. Public outcry for Shkreli's price hike was loud. Loud enough to garner the attention of Hilary Clinton, who called his actions "price gouging," and vowed to take on such pricing on speciality drugs. Shkreli's has since vowed to revisit the price hike.
3. So, is Shkreli a model capitalist or criminal?
Your Thoughts?Weigh In.